ESG

Appili Therapeutics lands a $40M deal to fight fungal threats, but with cash reserves low and loans due, can its science outpace its financial pressures?

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

With a 33% revenue surge and expanding margins, Capstone Green Energy's strategic pivot to data centers and EaaS is paying off, marking a major turnaround.

A new 'longevity center' in Naperville signals a growing trend in proactive health, but what does this mean for the Chicago wellness landscape?

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

With a promising heart failure drug in trials, the biotech aims to woo investors at the Oppenheimer conference to fund its attack on age-related diseases.

Celcuity adds Seagen commercial veteran Charles Romp to its board, a strategic move signaling its pivot from R&D to market readiness for gedatolisib.

With results expected to beat guidance, all eyes are on Progyny's upcoming earnings as a key indicator for the rapidly expanding corporate family-building industry.

Texas Athletics and supplement brand Humann partner to turn basketball games into a live lesson on heart health, blending science, sports, and marketing.

With rising diagnoses and an aging workforce, Parkinson's is no longer a retirement issue. Are Canadian companies prepared for this new reality?

A nonprofit's Super Bowl ad with Mike Tyson declared war on processed food. Who's behind the campaign, and can it change how America eats?

France bestows a knighthood on SCAD founder Paula Wallace for her transformative work in arts education and historic preservation in Provence.

A new J.D. Power study reveals that advanced technology, from infotainment to over-the-air software updates, is making modern vehicles less reliable.

DRiV's new copper-free Ferodo brake pads for commercial vehicles promise OE-quality stopping power while meeting tough new environmental regulations.

French flavor giant posts strong 2025 results despite currency woes, fueled by booming emerging markets and a deep commitment to natural, sustainable ingredients.

Dr. Ginna Laport, a leader from both pharma and academia, joins NMDP to spearhead a new initiative aimed at making life-saving cell therapies a reality for more patients.

Genesis deepens its community roots in Las Vegas with a $25k arts grant and a hands-on workshop, fueling opportunities for underserved youth.

A new 68-unit affordable senior community in Castle Hayne is secured by a key federal loan, highlighting a successful model for rural housing needs.

With strong Phase 1 data and key FDA backing, Trethera's TRE-515 is advancing as a 'pipeline-in-a-product' for a wide range of diseases.

Celebrating 160 years, this family-owned door maker defies trends by investing in US jobs, carbon-neutral tech, and a deep-rooted community legacy.